NCT06260709 - A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

February 29, 2028

Study Completion Date

August 15, 2028

Conditions

Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Interventions

DRUG

NNC6019-0001

Intravenous NNC6019-0001 every 4 weeks added to the standard of care until Week 140.

Trial Locations (33)

12808

II. interni klinika VFN - Kardiologie a angiologie, Prague

21201

Univ of MD Schl of Med, Baltimore

27100

Centro per lo Studio e la Cura delle Amiloidosi Sistemiche Fondazione IRCCS Policlinico San Matteo, Pavia

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

31059

Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-1, Toulouse

32224

Mayo Clinic Jacksonville, Jacksonville

48149

Uniklinik Münster, Klinik für Kardiologie I, Münster

Universitätsklinikum Münster - Klinik für Kardiologie I, Münster

55905

Mayo Clinic Rochester, Rochester

56124

Fondazione CNR-Regione Toscana Gabriele Monasterio, Pisa

Fondazione Toscana Gabriele Monasterio - Dipartimento Cardiotoracico - UOC Cardiologia e Medicina Cardiovascolare, Pisa

60208

NW Univ-Bluhm Cardiovasc Inst, Evanston

60611

NW Univ-Bluhm Cardiovasc Inst, Chicago

69120

UniklinikHeidelberg - Innere Med. III - Kardiologie, Angiologie, Pneumologie, Heidelberg

Universitätsklinik Heidelberg Innere Medizin III Kardiologie, Angiologie, Pneumologie, Heidelberg

81377

LMU Klinikum München Klinik und Poliklinik 1, München

85054

Mayo Clinic Arizona, Phoenix

90048

Cedars-Sinai Medical Center_Los Angeles, Los Angeles

94000

Ap-Hp-Hopital Henri Mondor, Créteil

94305

Stanford Hlth Cre-Boswell Clin, Stanford

97078

Universitatsklinikum Wurzburg AöR, Würzburg

Universitatsklinikum Würzburg - Zentrum für Herzinsuffizienz, Würzburg

T2N 4Z6

University of Calgary_Cardiology, Calgary

V5Z 1M9

Ctr for Cardiovascular Innovation, Vancouver

807-8556

Hospital of the University of Occupational and Environmental Health, Cardiology, Nephrology, Fukuoka

734-8551

Hiroshima University hospital, Cardiovascular Medicine, Hiroshima

860-8556

Kumamoto University Hospital, Cardiovascular Medicine, Kumamoto-shi, Kumamoto

390-8621

Shinshu University Hospital, Department of Neurology, Nagano

852-8501

Nagasaki University Hospital, Cardiovascular Medicine, Nagasaki

9713 GZ

UMC Groningen, Groningen

3584 CX

Universitair Medisch Centrum Utrecht, Utrecht

4835-044

Hospital da Senhora da Oliveira - Guimarães, Guimarães

Unidade Local de Saude do Alto Ave, E.P.E., Guimarães